HIV seroconversions and genotypic viral resistance profiles in the PrEP impact trial. Cartier A, Milinkovic A, Goodall L, Mora-Peris B, et al. HIV Med 2025 May 21. doi: 10.1111/hiv.70045.

Read + Share

Amedeo Smart

Independent Medical Education

Cartier A, Milinkovic A, Goodall L, Mora-Peris B, et al. HIV seroconversions and genotypic viral resistance profiles in the PrEP impact trial. HIV Med 2025 May 21. doi: 10.1111/hiv.70045.
PMID: 40400229